Tag: Palforzia (AR101)
This Holiday Season, See the Potential Impact that Peanut Allergy Treatment...
Did you know there’s a treatment option in addition to avoidance alone?
Notebooks, check. Backpack, check. Peanut allergy treatment, check. (Sponsored)
What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
USF Begins Recruitment for OIT Study Addressing 15 Food Allergies at...
Therapy will treat allergies to peanuts, almonds, cashew, hazelnuts, pecans, pistachios, walnuts, codfish, salmon, shrimp, sesame seed, soy, wheat, milk and eggs simultaneously.
Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...
Safety and efficacy increased over time with treatment.
How the First FDA-Approved Therapy for Peanut Allergy is Helping Families (Sponsored)
What is PALFORZIA?
PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis,...
Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...
Majority of patients experienced low rates of adverse events which declined in frequency and severity with continued treatment.
Peanut Allergy More Common in Adults Than Children, Many Report First...
Peanut allergy affects at least 4.5 million adults in the US.
Nestlé to Acquire Aimmune Therapeutics
Nestlé Health Science and Aimmune to create a global leader in food allergy prevention and treatment.
Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...
Peanut-allergic patients treated with Palforzia showed desensitization to peanut protein with a predictable safety profile at nine months
New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...
After 2 Years of Daily Treatment, More Than 80% of Patients Were Successfully Desensitized to 2000 mg Peanut Protein or Equivalent of About 14 Peanut Kernels.
